COVID-19 and Personalized Medicine: Current Status and Lessons Learned
14 September 2020
Watch the recorded virtual discussion about COVID-19 and Personalized Medicine organized by the Personalized Medicine Coalition.
Featuring
Scott Gottlieb, M.D., Resident Fellow, American Enterprise Institute
Antonio L. Andreu, M.D., Ph.D., Scientific Director, European Infrastructure for Translational Research
Michael Pellini, M.D., Managing Partner, Section 32
Michael Sherman, M.D., Senior Vice President, Chief Medical Officer, Harvard Pilgrim Health Care
Werner Verbiest, Strategic Partnerships and Alliances Leader, Janssen Pharmaceutical Companies of Johnson and Johnson
Jay G. Wohlgemuth, M.D., Senior Vice President, Chief Medical Officer, Quest Diagnostics
Synapse features
in relation to Covid-19Global resources
Industry resources
National government sites